Allianz Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-205,125
Closed -$1.24M 2116
2025
Q4
$1.24M Sell
205,125
-79,102
-28% -$471K ﹤0.01% 1662
2025
Q3
$1.62M Sell
284,227
-43,473
-13% -$222K ﹤0.01% 1578
2025
Q2
$1.65M Buy
327,700
+19,000
+6% +$102K ﹤0.01% 1535
2025
Q1
$2M Buy
308,700
+136,751
+80% +$1.22M ﹤0.01% 1488
2024
Q4
$1.26M Buy
171,949
+99,593
+138% +$786K ﹤0.01% 1580
2024
Q3
$542K Buy
+72,356
New +$628K ﹤0.01% 1835
2023
Q2
Sell
-22,394
Closed -$521K 2298
2023
Q1
$521K Buy
+22,394
New +$573K ﹤0.01% 1892
2022
Q2
Sell
-30,218
Closed -$777K 2438
2022
Q1
$777K Buy
30,218
+418
+1% +$12.4K ﹤0.01% 1970
2021
Q4
$1.24M Buy
29,800
+5,805
+24% +$227K ﹤0.01% 1810
2021
Q3
$1.04M Sell
23,995
-2,700
-10% -$117K ﹤0.01% 1913
2021
Q2
$1.26M Hold
26,695
﹤0.01% 1647
2021
Q1
$1.37M Buy
26,695
+2,395
+10% +$129K ﹤0.01% 1533
2020
Q4
$651K Buy
+24,300
New +$790K ﹤0.01% 1580

Other funds holding VIR